1. Clinical impact of soluble Neuropilin-1 in ovarian cancer patients and its association with its circulating ligands of the HGF/c-MET axis
   Daniel Martin Klotz et al, 2022, Frontiers in Oncology CrossRef
2. MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1
   Enrica Vescarelli et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
3. Early urinary protein changes during tumor formation in a NuTu-19 tail vein injection rat model
   Jing Wei et al, 2020, Scientific Reports CrossRef
4. The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer
   Eduardo Mello Rodrigues et al, 2023, Cancers CrossRef
5. Neuropilin 1 and Neuropilin 2: Cancer Progression and Biomarker Analysis
   Xiaoran Li et al, 2017, Biomarkers of the Tumor Microenvironment CrossRef
6. Global characterization of RNA editing in genetic regulation of multiple ovarian cancer subtypes
   Yulan Wang et al, 2024, Molecular Therapy - Nucleic Acids CrossRef
7. Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation
   F Shi et al, 2018, Oncogene CrossRef
8. Rational, computer-enabled peptide drug design: principles, methods, applications and future directions
   David J Diller et al, 2015, Future Medicinal Chemistry CrossRef